SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 27, 2002
                                                 -------------




                        Posteralley.com, Inc.
     -----------------------------------------------------------
     (Name of Small business Issuer as Specified in its Charter)

        Colorado                         000-31469              84-1509950
----------------------------            ------------      ----------------------
(State or other jurisdiction            (Commission          (I.R.S. Employer
    of incorporation)                   File Number)      Identification Number)


              2281 Guenette
           Ville Saint-Laurent
        Montreal, Quebec, Canada                                       HR4 2E9
--------------------------------------------                          ----------
    (Address of Principal Executive Offices)                          (Zip Code)



Registrant's telephone number, including area code  (514) 339-9355
                                                    --------------


















                                        1
<PAGE>






Item l.  Changes in Control of Registrant.
------------------------------------------

     On June 27, 2002, we announced our entry into a "Letter of Intent Regarding
Plan of Reorganization  and Acquisition with Medical  International  Technology,
Inc." (the "Agreement").  Medical International  Technology,  a company based in
Montreal, Canada, specializes in the research,  development,  marketing and sale
of a needle-free  jet injector  designed for humans and animals,  for single and
mass  vaccinations.  As of  the  date  of  this  report,  Medical  International
Technology is marketing  products  incorporating  this  needle-free  technology,
including AGROJET, MED-JET and PET-JET.

     As  part of the  Agreement,  we  agreed  to  change  our  name to  "Medical
International  Technology,  Inc." and change the OTCBB  symbol  under  which our
common stock trades on the Over-The-Counter Bulletin Board. Our common stock now
trades on the Over-The-Counter Bulletin Board under the new OTCBB symbol "MDIR."
In  connection  with  the  reorganization,  we  (i)  canceled  an  aggregate  of
24,388,000  shares  of common  stock,  representing  approximately  81.6% of our
29,900,000 shares of common stock then outstanding,  leaving 5,512,000 shares of
common stock  outstanding,  and (ii) issued 7,500,000  newly-issued,  restricted
shares of common stock in exchange for all of the issued and outstanding  shares
of 4063732  Canada,  Inc.,  numbered  Canadian  company,  which will own Medical
International  Technology.  We also effected a .4:1 stock dividend  described in
more detail under Item 5. below to  shareholders  of record on June 25, 2002. We
had 13,012,000 shares of common stock outstanding immediately prior to the stock
dividend and 18,216,800 shares of common stock outstanding immediately following
the stock dividend,  of which 10,500,000  restricted  shares of common stock are
owned by  4063732  Canada,  Inc.  We have been  pursuing  Medical  International
Technology's business plan since the date of the reorganization  provided for in
the Agreement.

     Mr.  Scott M.  Thornock  resigned as the  President,  the  Treasurer  and a
director of Posteralley.com and Mr. Bruce A. Capra resigned as the Secretary and
a  director  of  Posteralley.com  on June  17,  2002,  in  connection  with  the
reorganization.  Executive  officers  and  directors  of  Medical  International
Technology  were elected to fill the vacancies  created by the  resignations  of
Messrs.   Thornock   and  Capra.   Mr.   Karim   Menassa   was  elected  as  our
President/Chairman  and Mr.  Michel  Bayouk was elected as the  Secretary  and a
director of Posteralley.com.  The balance of Mr. Thornock's 18,968,000 shares of
common stock  (1,344,200 of Mr.  Thornock's  shares  pre-9:1 stock dividend were
canceled  on April  17,  2002)  and all of Mr.  Capra's  3,600,000  shares  were
included in the 24,388,000 shares canceled in the reorganization. The balance of
1,820,000  shares of common stock canceled was owned by Patricia Cudd,  Esq. Mr.
Jeffery H. Lee,  whose 10,000 shares of common stock pre-9:1 stock dividend were
canceled on April 17,  2002,  resigned as the Vice  President  and a director of
Posteralley.com  on June 13, 2002.  The 9:1 stock  dividend we declared on April
17, 2002,  to  shareholders  of record on April 19,  2002,  is described in more
detail under Item 5. below.


Item 5.  Other Events and Regulation FD Disclosure.
---------------------------------------------------

     In June 2002,  Posteralley.com declared a stock dividend to shareholders of
record as of 8:00 a.m., Eastern Standard Time, on June 25, 2002, on the basis of
four-tenths  of a share of common  stock for each one share of common stock then


                                        2
<PAGE>






outstanding.  The  payment  date and time for the stock  dividend  were June 26,
2002, at 8:00 a.m.,  Eastern  Standard Time. As a result of the stock  dividend,
each shareholder of Posteralley.com  received four-tenths of an additional share
of common  stock for each one  share of common  stock  owned of record as of the
record date and time.  Subsequent to 8:00 a.m.,  Eastern  Standard  Time, on the
payment date,  we had  18,216,800  shares of common stock,  $.0001 par value per
share, outstanding as a result of the stock dividend.

     On April 17, 2002, we declared a stock dividend to  shareholders  of record
as of 8:00 a.m.,  Eastern Standard Time, on April 19, 2002, on the basis of nine
shares of common stock for each one share of common stock then outstanding.  The
payment date and time for the stock  dividend were April 26, 2002, at 8:00 a.m.,
Eastern  Standard Time. As a result of the stock dividend,  each  shareholder of
Posteralley.com  received  nine  additional  shares of common stock for each one
share of common stock owned of record as of the record date and time. Subsequent
to 8:00 a.m.,  Eastern Standard Time, on the payment date,  Posteralley.com  had
29,900,000 shares of common stock, $.0001 par value per share,  outstanding as a
result of the stock dividend.

     The dividends were not mandatory exchanges.  No certificates for fractional
shares of common stock were issued. Instead,  certificates for fractional shares
of common stock were rounded up to the next whole share.


Item 7.  Financial Statements and Exhibits.
-------------------------------------------

     (c)  The Press  Release of  Posteralley.com,  Inc.,  dated  June 27,  2002,
captioned  "PosterAlley.com Inc. (sic) Acquires Medical International Technology
Inc." is filed as an exhibit to this Current Report on Form 8-K pursuant to this
Item 7(c).


                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:    July 12, 2002                   POSTERALLEY.COM, INC.
                                                 (Registrant)



                                         By: /s/ Karim Menassa
                                            ----------------------------------
                                             Karim Menassa, President/Chairman




                                        3
[{"type": "8-K", "sequence": "1", "filename": "poster8k062702.txt", "description": "POSTERALLEY.COM 8K, 06.27.02", "secsgml_size_bytes": 7724}]
{"company-data": {"conformed-name": "POSTERALLEY COM INC", "cik": "0001112372", "assigned-sic": "7389", "irs-number": "841509950", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-31469", "film-number": "02704298"}, "business-address": {"street1": "650 S. CHERRY ST.", "street2": "STE. 310", "city": "DENVER", "state": "CO", "zip": "80246", "phone": "3036299751"}, "mail-address": {"street1": "650 S. CHERRY ST.", "street2": "STE. 310", "city": "DENVER", "state": "CO", "zip": "80246"}}
SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 27, 2002
                                                 -------------

                        Posteralley.com, Inc.
     -----------------------------------------------------------
     (Name of Small business Issuer as Specified in its Charter)

        Colorado                         000-31469              84-1509950
----------------------------            ------------      ----------------------
(State or other jurisdiction            (Commission          (I.R.S. Employer
    of incorporation)                   File Number)      Identification Number)

              2281 Guenette
           Ville Saint-Laurent
        Montreal, Quebec, Canada                                       HR4 2E9
--------------------------------------------                          ----------
    (Address of Principal Executive Offices)                          (Zip Code)

Registrant's telephone number, including area code  (514) 339-9355
                                                    --------------

                                        1
Item l.  Changes in Control of Registrant.
------------------------------------------

     On June 27, 2002, we announced our entry into a "Letter of Intent Regarding
Plan of Reorganization  and Acquisition with Medical  International  Technology,
Inc." (the "Agreement").  Medical International  Technology,  a company based in
Montreal, Canada, specializes in the research,  development,  marketing and sale
of a needle-free  jet injector  designed for humans and animals,  for single and
mass  vaccinations.  As of  the  date  of  this  report,  Medical  International
Technology is marketing  products  incorporating  this  needle-free  technology,
including AGROJET, MED-JET and PET-JET.

     As  part of the  Agreement,  we  agreed  to  change  our  name to  "Medical
International  Technology,  Inc." and change the OTCBB  symbol  under  which our
common stock trades on the Over-The-Counter Bulletin Board. Our common stock now
trades on the Over-The-Counter Bulletin Board under the new OTCBB symbol "MDIR."
In  connection  with  the  reorganization,  we  (i)  canceled  an  aggregate  of
24,388,000  shares  of common  stock,  representing  approximately  81.6% of our
29,900,000 shares of common stock then outstanding,  leaving 5,512,000 shares of
common stock  outstanding,  and (ii) issued 7,500,000  newly-issued,  restricted
shares of common stock in exchange for all of the issued and outstanding  shares
of 4063732  Canada,  Inc.,  numbered  Canadian  company,  which will own Medical
International  Technology.  We also effected a .4:1 stock dividend  described in
more detail under Item 5. below to  shareholders  of record on June 25, 2002. We
had 13,012,000 shares of common stock outstanding immediately prior to the stock
dividend and 18,216,800 shares of common stock outstanding immediately following
the stock dividend,  of which 10,500,000  restricted  shares of common stock are
owned by  4063732  Canada,  Inc.  We have been  pursuing  Medical  International
Technology's business plan since the date of the reorganization  provided for in
the Agreement.

     Mr.  Scott M.  Thornock  resigned as the  President,  the  Treasurer  and a
director of Posteralley.com and Mr. Bruce A. Capra resigned as the Secretary and
a  director  of  Posteralley.com  on June  17,  2002,  in  connection  with  the
reorganization.  Executive  officers  and  directors  of  Medical  International
Technology  were elected to fill the vacancies  created by the  resignations  of
Messrs.   Thornock   and  Capra.   Mr.   Karim   Menassa   was  elected  as  our
President/Chairman  and Mr.  Michel  Bayouk was elected as the  Secretary  and a
director of Posteralley.com.  The balance of Mr. Thornock's 18,968,000 shares of
common stock  (1,344,200 of Mr.  Thornock's  shares  pre-9:1 stock dividend were
canceled  on April  17,  2002)  and all of Mr.  Capra's  3,600,000  shares  were
included in the 24,388,000 shares canceled in the reorganization. The balance of
1,820,000  shares of common stock canceled was owned by Patricia Cudd,  Esq. Mr.
Jeffery H. Lee,  whose 10,000 shares of common stock pre-9:1 stock dividend were
canceled on April 17,  2002,  resigned as the Vice  President  and a director of
Posteralley.com  on June 13, 2002.  The 9:1 stock  dividend we declared on April
17, 2002,  to  shareholders  of record on April 19,  2002,  is described in more
detail under Item 5. below.

Item 5.  Other Events and Regulation FD Disclosure.
---------------------------------------------------

     In June 2002,  Posteralley.com declared a stock dividend to shareholders of
record as of 8:00 a.m., Eastern Standard Time, on June 25, 2002, on the basis of
four-tenths  of a share of common  stock for each one share of common stock then

                                        2
outstanding.  The  payment  date and time for the stock  dividend  were June 26,
2002, at 8:00 a.m.,  Eastern  Standard Time. As a result of the stock  dividend,
each shareholder of Posteralley.com  received four-tenths of an additional share
of common  stock for each one  share of common  stock  owned of record as of the
record date and time.  Subsequent to 8:00 a.m.,  Eastern  Standard  Time, on the
payment date,  we had  18,216,800  shares of common stock,  $.0001 par value per
share, outstanding as a result of the stock dividend.

     On April 17, 2002, we declared a stock dividend to  shareholders  of record
as of 8:00 a.m.,  Eastern Standard Time, on April 19, 2002, on the basis of nine
shares of common stock for each one share of common stock then outstanding.  The
payment date and time for the stock  dividend were April 26, 2002, at 8:00 a.m.,
Eastern  Standard Time. As a result of the stock dividend,  each  shareholder of
Posteralley.com  received  nine  additional  shares of common stock for each one
share of common stock owned of record as of the record date and time. Subsequent
to 8:00 a.m.,  Eastern Standard Time, on the payment date,  Posteralley.com  had
29,900,000 shares of common stock, $.0001 par value per share,  outstanding as a
result of the stock dividend.

     The dividends were not mandatory exchanges.  No certificates for fractional
shares of common stock were issued. Instead,  certificates for fractional shares
of common stock were rounded up to the next whole share.

Item 7.  Financial Statements and Exhibits.
-------------------------------------------

     (c)  The Press  Release of  Posteralley.com,  Inc.,  dated  June 27,  2002,
captioned  "PosterAlley.com Inc. (sic) Acquires Medical International Technology
Inc." is filed as an exhibit to this Current Report on Form 8-K pursuant to this
Item 7(c).

                                   SIGNATURES

     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.

Date:    July 12, 2002                   POSTERALLEY.COM, INC.
                                                 (Registrant)

                                         By: /s/ Karim Menassa
                                            ----------------------------------
                                             Karim Menassa, President/Chairman

                                        3